Literature DB >> 22100636

Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.

Jesús Castilla1, Víctor Martínez-Artola, Esther Salcedo, Iván Martínez-Baz, Manuel García Cenoz, Marcela Guevara, Nerea Alvarez, Fátima Irisarri, Julio Morán, Aurelio Barricarte.   

Abstract

We evaluated the 2010-2011 seasonal influenza vaccine effectiveness in preventing hospitalizations. Using healthcare databases we defined the target population for vaccination in Navarre, Spain, consisting of 217,320 people with major chronic conditions or aged 60 years and older. All hospitalized patients with influenza-like illness (ILI) were swabbed for influenza testing. A total of 269 patients with ILI were hospitalized and 61 of them were found positive for influenza virus: 58 for A(H1N1)2009 and 3 for B virus. The incidence rates of hospitalization with laboratory-confirmed influenza were compared by vaccination status. In the Cox regression model adjusted for sex, age, children in the household, urban/rural residence, comorbidity, pandemic vaccination, pneumococcal vaccination, outpatient visits and hospitalization in the previous year, the seasonal vaccine effectiveness was 58% (95% CI: 16-79%). The nested test-negative case-control analysis gave an adjusted estimate of 59% (95% CI: 4-83%). These results suggest a moderate effect of the 2010-2011 seasonal influenza vaccine in preventing hospitalization in a risk population. The close estimates obtained in the cohort and the test-negative case-control analyses suggest good control of biases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100636     DOI: 10.1016/j.vaccine.2011.11.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Authors:  Iván Martínez-Baz; Ana Navascués; Francisco Pozo; Judith Chamorro; Esther Albeniz; Itziar Casado; Gabriel Reina; Manuel García Cenoz; Carmen Ezpeleta; Jesús Castilla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

3.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

4.  Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years.

Authors:  Qingxia Chen; Marie R Griffin; Hui Nian; Yuwei Zhu; John V Williams; Kathryn M Edwards; H Keipp Talbot
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

5.  The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Authors:  Melissa K Andrew; Vivek Shinde; Lingyun Ye; Todd Hatchette; François Haguinet; Gael Dos Santos; Janet E McElhaney; Ardith Ambrose; Guy Boivin; William Bowie; Ayman Chit; May ElSherif; Karen Green; Scott Halperin; Barbara Ibarguchi; Jennie Johnstone; Kevin Katz; Joanne Langley; Jason Leblanc; Mark Loeb; Donna MacKinnon-Cameron; Anne McCarthy; Allison McGeer; Jeff Powis; David Richardson; Makeda Semret; Grant Stiver; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

Review 6.  Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Authors:  Marc Rondy; Nathalie El Omeiri; Mark G Thompson; Alain Levêque; Alain Moren; Sheena G Sullivan
Journal:  J Infect       Date:  2017-09-18       Impact factor: 6.072

7.  Epidemiological factors related to hospitalization due to influenza in children below 6 months of age.

Authors:  J Bustamante; I Calzado; T Sainz; C Calvo; T Del Rosal; A Méndez-Echevarría
Journal:  Eur J Pediatr       Date:  2017-08-29       Impact factor: 3.183

Review 8.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

9.  Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.

Authors:  H Keipp Talbot; Hui Nian; Qingxia Chen; Yuwei Zhu; Kathryn M Edwards; Marie R Griffin
Journal:  Vaccine       Date:  2016-02-28       Impact factor: 3.641

10.  Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season.

Authors:  Alessandra Falchi; Cecile Souty; Marie-Lise Grisoni; Anne Mosnier; Thomas Hanslik; Isabelle Daviaud; Laurent Varesi; Solen Kerneis; Fabrice Carrat; Thierry Blanchon
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.